Bausch Health Companies (NYSE: BHC) — Perfil da empresa, notícias e dados financeiros
Bausch Health develops and markets a range of pharmaceutical and medical products across various therapeutic areas.
Bausch Health Companies
Bausch Health (NYSE:BHC) is a diverse healthcare company engaged in developing, manufacturing, and marketing a wide range of pharmaceutical, medical device, and over-the-counter products. Its operations span across several therapeutic areas including eye health, gastroenterology, and dermatology, aiming to improve people’s lives with its products. The company is dedicated to advancing its portfolio through innovative treatments and accessible healthcare solutions. Bausch Health's objective encompasses a commitment to enhancing patient care while strategically growing its global presence through research and development, as well as partnerships and acquisitions.
Resumo
Operações
Produtos e/ou serviços de Bausch Health Companies
- Lumify (brimonidine tartrate) eye drops provide reduction of redness to help eyes appear whiter and brighter.
- Lotemax (loteprednol etabonate) is a corticosteroid for eye inflammation and pain treatment.
- Xifaxan (rifaximin) is indicated for irritable bowel syndrome with diarrhea and hepatic encephalopathy.
- Duobrii (halobetasol propionate and tazarotene) lotion treats plaque psoriasis in adults.
- Elidel (pimecrolimus) cream is used for the treatment of atopic dermatitis (eczema) to relieve skin inflammation and itching.
equipe executiva do Bausch Health Companies
- Thomas J. AppioCEO & Director
- Jean-Jacques CharhonExecutive VP & CFO
- Seana CarsonExecutive VP & General Counsel
- Aimee J. LenarPresident of US Pharma
- Mirza DautbegovicExecutive VP & COO
- Steven H. LeeSenior VP, Controller & Chief Accounting Officer
- Garen SarafianVP & Head of Investor Relations
- Kathleen FitzpatrickExecutive VP and Chief HR & Communications Officer
- Cees HeimanSenior Vice President of Europe & Canada
- Jiny KimSenior Vice President of Solta Medical
Últimas notícias sobre a Bausch Health Companies
Principais indicadores financeiros
Resultados divulgados pela Bausch Health Companies, em USD.
- Cap. de mercado
- 2,4 bi
- Receita (TTM)
- 10,9 bi
- P/L
- —
- LPA (diluído, TTM)
- -3.0
- Dividend yield
- —
- Margem de lucro
- -10.1%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 10,3 bi | 2,2 bi | 157 mi | |
| 9,6 bi | 1,5 bi | -46 mi | |
| 8,8 bi | 963 mi | -592 mi | |
| 8,1 bi | 454 mi | -225 mi |